Hosted By
Glucagon-Like-Peptide-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for their effects on weight loss and metabolic health. Emerging research suggests that GLP1-Receptor Agonists could be supportive in managing inflammatory symptoms associated with Mast Cell Activation Syndrome (MCAS). Although research is currently limited, Anna talks about what we know so far and her experience with clients taking these drugs in clinical practice.
Useful Links
Research Paper: https://www.sciencedirect.com/science/article/abs/pii/S0002962925011061
Take the Chronic Fatigue Quiz: https://app.annamarsh.co.uk/quiz-page
Instagram: https://www.instagram.com/anna__marsh_
Work with me: https://annamarsh.co.uk/work-together/
Website: http://annamarsh.co.uk/
Join the Nurturing Resilience Subscription: https://annamarsh.co.uk/nurturing-resilience/
Shownotes Fasting is a practice that can be controversial in the healthcare space. Some people love it, others feel that it can do more...
Many women experience crashes, flares and setbacks around their menstrual cycle. The natural fluctuation in hormone levels can be destabilising to sensitive and unstable...
One of the most frightening moments in recovery can be when symptoms suddenly return after a long period of stability. And many people immediately...
